Inozyme Pharma
Inozyme Pharma Logo
About Inozyme Pharma
Inozyme Pharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for rare diseases involving abnormal mineralization of the vasculature, soft tissue, and skeleton. Its lead product candidate, INZ-701, is a recombinant fusion protein in development for the treatment of ENPP1 and ABCC6 deficiencies, as well as calciphylaxis and related disorders. The company is dedicated to advancing therapies for patients with limited or no approved treatment options.
Address
321 Summer Street, Suite 400
Boston, 02210
United States
Year founded
2015
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
